Company Overview
- Headquarters
- Delft
- Website
- spektrax.com
- Employees
- 4
- Founded in
- 2020
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$1B
Who is SPEKTRAX
SPEKTRAX is a small biotechnology company based in Delft, United States, with 5 to 9 employees. Founded with the mission of combating the COVID-19 pandemic, SPEKTRAX focuses on developing innovative diagnostic solutions. The company is dedicated to creating a rapid viral pathogen detection test, specifically targeting the COVID-19 virus. This test aims to provide reliable results within minutes, eliminating the need for traditional laboratory processing. SPEKTRAX envisions a future where individuals can confidently return to their daily lives, work, and travel, empowered by the certainty and trust offered by their diagnostic technology. SPEKTRAX differentiates itself by focusing on speed and accessibility. Their rapid test technology aims to bridge the gap in timely diagnosis, enabling quicker response times and potentially mitigating the spread of infectious diseases. For more information about SPEKTRAX and their groundbreaking work, visit their website at spektrax.com.
Companies Similar to SPEKTRAX
Analyze industry trends and opportunities by examining competitors and companies comparable to SPEKTRAX, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 1M | 11 | 2007 | ||
| 1M | 4 | |||
| 1M | 4 | Washington, WA | 1994 | |
| 1M | 32 | New York, NY | 1983 | |
| 1M | 3 |